# Reducing Opioid Use After Upper Extremity Surgery: Testing Lower Prescriptions and Pill Quantity

> **NCT07750639** · PHASE4 · ENROLLING_BY_INVITATION · sponsor: **AdventHealth** · enrollment: 300 (estimated)

## Conditions studied

- Opioid Abuse (Disorder)
- Opioid Analgesia
- Opioid Analgesic Adverse Reaction
- Opioid Consumption

## Interventions

- **DRUG:** Naproxen
- **DRUG:** Acetaminophen
- **DRUG:** oxycodone
- **DRUG:** Gabapentin

## Key facts

- **NCT ID:** NCT07750639
- **Lead sponsor:** AdventHealth
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2024-08-01
- **Primary completion:** 2027-11-30
- **Final completion:** 2027-12-30
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2026-10-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07750639

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07750639, "Reducing Opioid Use After Upper Extremity Surgery: Testing Lower Prescriptions and Pill Quantity". Retrieved via MORVS 2026-11-03 from https://api.morvs.ai/clinical/NCT07750639. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
